Onsdag 28 Oktober | 18:13:33 Europe / Stockholm

All ägardata du vill ha finns i Holdings!

Clavister - A Period of Transition

2021-08-31 10:20:00

Redeye has a mixed view of Clavister's 2Q21 – net sales were softer than forecast while subscription sales and order intake surprised positively. We maintain an optimistic operational outlook and expect a robust second half of 2021. We decrease our Base Case slightly but continue to see value (40%+) at current levels.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/